Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-096898
Filing Date
2016-04-28
Accepted
2016-04-28 13:50:12
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v437517_10q.htm 10-Q 423962
2 EXHIBIT 31.1 v437517_ex31-1.htm EX-31.1 8749
3 EXHIBIT 31.2 v437517_ex31-2.htm EX-31.2 9307
4 EXHIBIT 32.1 v437517_ex32-1.htm EX-32.1 4929
  Complete submission text file 0001144204-16-096898.txt   2941771

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arth-20160331.xml EX-101.INS 498572
6 XBRL TAXONOMY EXTENSION SCHEMA arth-20160331.xsd EX-101.SCH 31893
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arth-20160331_cal.xml EX-101.CAL 20759
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arth-20160331_def.xml EX-101.DEF 224429
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arth-20160331_lab.xml EX-101.LAB 267857
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arth-20160331_pre.xml EX-101.PRE 249326
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-475-5254
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 161598930
SIC: 5531 Retail-Auto & Home Supply Stores